Although B cells from HC and RA patients influenced CD4+ T cell response, they probably use another pathway in addition to PD-1/PD-L1 as, interestingly, blockade of the PD-1/PD-L1 interaction was not sufficient to reverse CD4+ T cell suppression. This evidence concerns the gene CD4 and rheumatoid arthritis.